Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
George King Bio-Medical is a leading supplier of clinical hemostasis and coagulation products used in diagnostic laboratories worldwide. The company provides fresh frozen plasmas from human donors with specific congenital coagulation factor deficiencies as well as normal and abnormal control plasmas for laboratory use[1][2][3]. There are no therapeutic drugs or clinical trial results; the focus is on supplying high-quality reagents for diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingbio Medical.